Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
ChipMOS TECHNOLOGIES INC is a semiconductors business based in the US. ChipMOS TECHNOLOGIES shares (IMOS) are listed on the NASDAQ and all prices are listed in US Dollars. ChipMOS TECHNOLOGIES employs 5,688 staff and has a market cap (total outstanding shares value) of USD$883.7 million.
|Latest market close||USD$25.72|
|52-week range||USD$14.2 - USD$26.07|
|50-day moving average||USD$22.7441|
|200-day moving average||USD$21.2186|
|Wall St. target price||USD$20|
|Dividend yield||USD$1.23 (5.11%)|
|Earnings per share (TTM)||USD$0.42|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-14)||-2.09%|
|1 month (2020-12-21)||7.12%|
|3 months (2020-10-21)||28.47%|
|6 months (2020-07-21)||19.13%|
|1 year (2020-01-21)||16.91%|
|2 years (2019-01-18)||56.54%|
|3 years (2018-01-19)||40.93%|
|5 years (2016-01-21)||42.89%|
Valuing ChipMOS TECHNOLOGIES stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ChipMOS TECHNOLOGIES's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
ChipMOS TECHNOLOGIES's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 57x. In other words, ChipMOS TECHNOLOGIES shares trade at around 57x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
ChipMOS TECHNOLOGIES's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.13. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into ChipMOS TECHNOLOGIES's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Gross profit TTM||USD$3.9 billion|
|Return on assets TTM||5.95%|
|Return on equity TTM||10.89%|
|Market capitalisation||USD$883.7 million|
TTM: trailing 12 months
There are currently 7,588 ChipMOS TECHNOLOGIES shares held short by investors – that's known as ChipMOS TECHNOLOGIES's "short interest". This figure is 24.8% down from 10,094 last month.
There are a few different ways that this level of interest in shorting ChipMOS TECHNOLOGIES shares can be evaluated.
ChipMOS TECHNOLOGIES's "short interest ratio" (SIR) is the quantity of ChipMOS TECHNOLOGIES shares currently shorted divided by the average quantity of ChipMOS TECHNOLOGIES shares traded daily (recently around 9033.3333333333). ChipMOS TECHNOLOGIES's SIR currently stands at 0.84. In other words for every 100,000 ChipMOS TECHNOLOGIES shares traded daily on the market, roughly 840 shares are currently held short.
However ChipMOS TECHNOLOGIES's short interest can also be evaluated against the total number of ChipMOS TECHNOLOGIES shares, or, against the total number of tradable ChipMOS TECHNOLOGIES shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ChipMOS TECHNOLOGIES's short interest could be expressed as 0% of the outstanding shares (for every 100,000 ChipMOS TECHNOLOGIES shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable ChipMOS TECHNOLOGIES shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ChipMOS TECHNOLOGIES.
Find out more about how you can short ChipMOS TECHNOLOGIES stock.
Dividend payout ratio: 259.13% of net profits
Recently ChipMOS TECHNOLOGIES has paid out, on average, around 259.13% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 5.11% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), ChipMOS TECHNOLOGIES shareholders could enjoy a 5.11% return on their shares, in the form of dividend payments. In ChipMOS TECHNOLOGIES's case, that would currently equate to about $1.23 per share.
ChipMOS TECHNOLOGIES's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
ChipMOS TECHNOLOGIES's most recent dividend payout was on 7 August 2020. The latest dividend was paid out to all shareholders who bought their shares by 1 July 2020 (the "ex-dividend date").
ChipMOS TECHNOLOGIES's shares were split on 2 November 2018. This wouldn't directly have changed the overall worth of your ChipMOS TECHNOLOGIES shares – just the quantity. However, indirectly, the new INF% higher share price could have impacted the market appetite for ChipMOS TECHNOLOGIES shares which in turn could have impacted ChipMOS TECHNOLOGIES's share price.
Over the last 12 months, ChipMOS TECHNOLOGIES's shares have ranged in value from as little as $14.2 up to $26.07. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ChipMOS TECHNOLOGIES's is 0.5623. This would suggest that ChipMOS TECHNOLOGIES's shares are less volatile than average (for this exchange).
ChipMOS TECHNOLOGIES INC. researches, develops, manufactures, and sells high integration and high precision integrated circuits, and related assembly and testing services. The company operates through Testing; Assembly; Testing and Assembly for Liquid Crystal Display and Other Flat-Panel Display Driver Semiconductors; and Bumping segments. It provides a range of back-end assembly and test services, including engineering test, wafer probing and final test of memory and logic/mixed-signal semiconductors, as well as leadframe-and organic substrate-based package assembly services for memory and logic/mixed-signal semiconductors; and gold bumping, reel to reel assembly, and test services for LCD and other flat-panel display driver semiconductors. The company's semiconductors are used in personal computers; graphics applications, such as game consoles; communications equipment; mobile products comprising cellular handsets, tablets, and consumer electronic products; and automotive/industry and display applications, such as display panels. It serves customers in Taiwan, Japan, Singapore, and internationally. The company was founded in 1997 and is headquartered in Hsinchu, Taiwan.
Everything we know about the NLS Pharmaceutics Ltd IPO, plus information on how to buy in.
Everything we know about the GitLab IPO, plus information on how to buy in.
Everything we know about the Longeveron LLC IPO, plus information on how to buy in.
Everything we know about the Signify Health Inc IPO, plus information on how to buy in.
Everything we know about the Biophytis SA IPO, plus information on how to buy in.
Everything we know about the NexImmune Inc IPO, plus information on how to buy in.
Everything we know about the Adagene Inc IPO, plus information on how to buy in.
Everything we know about the Cloopen Group Holding Limited IPO, plus information on how to buy in.
Everything we know about the Decipher Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Proterra IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.